MediWound LtdMDWD
Price$13.60Intrinsic value$16.7223% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $17M-16.1% YoYTTM through 31 Dec 2025
Net Income -$23.9MTTM through 31 Dec 2025
Free Cash Flow -$21.6MTTM through 31 Dec 2025

Margins

Current
Gross Margin19.2%
EBITDA Margin-145.5%
Operating Margin-149.0%
Net Margin-140.8%

Returns

-54.7%ROE
-27.7%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.33x
Net Debt-$53.6Mnet cash position
Cash & Equivalents$4.8M

Quality Metrics

Piotroski F-Score3 / 9
FCF Margin-127.5%
Rule of 40-87.9
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $17M
Diluted EPS
'17'18'21'22'23'24'25
FY2025: $-2.10

Dividend

No dividend

Capital Allocation

Capex Intensity32.5%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.